We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cie de SaintGobain | EU:SGO | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.72 | -2.01% | 84.06 | 84.04 | 86.48 | 86.20 | 84.06 | 85.70 | 1,101,889 | 16:40:00 |
By Kathryn Hardison
International stocks trading in New York closed mostly lower on Thursday.
The S&P/BNY Mellon index of American depositary receipts fell 0.3% to 126.61. The European index decreased 0.4% to 118.30, the Asian index fell 0.6% to 151.48, the Latin American index rose 2.1% to 187.95 and the emerging markets index decreased 0.6% to 263.37.
Compagnie de Saint-Gobain SA and GSK PLC were among the companies with ADRs that traded actively.
ADRs of Compagnie de Saint-Gobain SA fell 1.8% after the company said it received all outstanding regulatory approvals for its acquisition of U.S. peer GCP Applied Technologies Inc. The all-cash deal, previously valued at $2.3 billion, will be completed next week.
ADRs of GSK PLC rose 0.8% after the company said it signed an exclusive license agreement with Spero Therapeutics Inc. to commercialize tebipenem HBr, an antibiotic that may treat complicated urinary tract infections. The potential treatment is currently in late-stage studies.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
September 22, 2022 18:39 ET (22:39 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Cie de SaintGobain Chart |
1 Month Cie de SaintGobain Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions